Thomas John C
SEC insider (Form 3/4/5 filer). CIK 0001424620. Director at Dogwood Therapeutics, Inc. (DWTX). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in ALPHARETTA, GA.
Companies Thomas John C has filed insider reports for
- Dogwood Therapeutics, Inc. (DWTX): Director
Thomas John C
CIK: 0001424620
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dogwood Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
16.8K shares- - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
2.4K shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
210 shares- - Jun 18, 2025DWTX
Dogwood Therapeutics, Inc.
AwardDirectStock Option (right to buy)
210 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 16,800 | - | - | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 2,362 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 210 | - | - | Direct |
| Jun 18, 2025 | DWTX Dogwood Therapeutics, Inc. | Award Stock Option (right to buy) | 210 | - | - | Direct |
1-4 of 4 transactions